{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:00:46Z","timestamp":1778868046564,"version":"3.51.4"},"reference-count":81,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012164","name":"National High-tech Research and Development Program","doi-asserted-by":"publisher","award":["2019YFC1711400"],"award-info":[{"award-number":["2019YFC1711400"]}],"id":[{"id":"10.13039\/501100012164","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2018ZX09201-011"],"award-info":[{"award-number":["2018ZX09201-011"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2018ZX09301-011-003"],"award-info":[{"award-number":["2018ZX09301-011-003"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chinese Herbal Medicines"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.chmed.2023.02.002","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T13:57:42Z","timestamp":1680011862000},"page":"169-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinical antitumor application and pharmacological mechanisms of Dahuang Zhechong Pill"],"prefix":"10.1016","volume":"15","author":[{"given":"Yingying","family":"Tian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beibei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shangyue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yilin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailuan","family":"Pei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiqiu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeping","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhibin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.chmed.2023.02.002_b0005","first-page":"462","article-title":"Effect of Dahuang Zhechong Pill on survinvin expression in S180 tumor cell","volume":"30","author":"Ai","year":"2012","journal-title":"Chinese Archives of Traditional Chinese Medicine"},{"key":"10.1016\/j.chmed.2023.02.002_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103535","article-title":"Tumor-treating fields: A fourth modality in cancer treatment, new practice updates","volume":"168","author":"Arvind","year":"2021","journal-title":"Critical Reviews in Oncology\/Hematology"},{"issue":"Suppl 2","key":"10.1016\/j.chmed.2023.02.002_b0015","doi-asserted-by":"crossref","first-page":"64S","DOI":"10.2967\/jnumed.107.046391","article-title":"Imaging of cell proliferation: Status and prospects","volume":"49","author":"Bading","year":"2008","journal-title":"Journal of Nuclear Medicine"},{"issue":"16","key":"10.1016\/j.chmed.2023.02.002_b0020","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1002\/cncr.33587","article-title":"The ever-increasing importance of cancer as a leading cause of premature death worldwide","volume":"127","author":"Bray","year":"2021","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.chmed.2023.02.002_b0025","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.3390\/ijms21093233","article-title":"Mechanisms of multidrug resistance in cancer chemotherapy","volume":"21","author":"Bukowski","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"4","key":"10.1016\/j.chmed.2023.02.002_b0030","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2174\/1568009620666200115162814","article-title":"Targeting proliferating cell nuclear antigen (PCNA) as an effective strategy to inhibit tumor cell proliferation","volume":"20","author":"Cardano","year":"2020","journal-title":"Current Cancer Drug Targets"},{"issue":"7","key":"10.1016\/j.chmed.2023.02.002_b0035","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","article-title":"Targeting apoptosis in cancer therapy","volume":"17","author":"Carneiro","year":"2020","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"3","key":"10.1016\/j.chmed.2023.02.002_b0040","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/sj.leu.2402824","article-title":"Involvement of PI3K\/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: A target for cancer chemotherapy","volume":"17","author":"Chang","year":"2003","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.chmed.2023.02.002_b0045","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.trecan.2019.02.003","article-title":"Polytherapy and targeted cancer drug resistance","volume":"5","author":"Chatterjee","year":"2019","journal-title":"Trends in Cancer"},{"key":"10.1016\/j.chmed.2023.02.002_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.111878","article-title":"Dahuang Zhechong Pill suppresses colorectal cancer liver metastasis via ameliorating exosomal CCL2 primed pre-metastatic niche","volume":"238","author":"Chen","year":"2019","journal-title":"Journal of Ethnopharmacology"},{"issue":"5","key":"10.1016\/j.chmed.2023.02.002_b0055","doi-asserted-by":"crossref","first-page":"e5305","DOI":"10.1002\/bmc.5305","article-title":"Study on the material basis of Dahuang Zhechong pill of anti-hepatoma effect by promoting vascular normalization","volume":"36","author":"Chen","year":"2022","journal-title":"Biomedical Chromatography"},{"issue":"2","key":"10.1016\/j.chmed.2023.02.002_b0060","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S1875-5364(22)60160-2","article-title":"Dahuang Zhechong pills inhibit liver cancer growth in a mouse model by reversing Treg\/Th1 balance","volume":"20","author":"Chen","year":"2022","journal-title":"Chinese Journal of Natural Medicines"},{"issue":"3","key":"10.1016\/j.chmed.2023.02.002_b0065","first-page":"722","article-title":"Effect of Dahuang Zhechong Pills combined with TACE on VEGF, MMP-2, TGF-\u03b21 and immune function of patients with primary liver cancer (blood stasis and collaterals blocking type)","volume":"46","author":"Dai","year":"2021","journal-title":"China Journal of Chinese Materia Medica"},{"issue":"1","key":"10.1016\/j.chmed.2023.02.002_b0070","first-page":"1","article-title":"Inhibitory effects of Dahuang Zhechong Pill on AOM\/DSS-induced colitis-associated cancer in mice","volume":"29","author":"Dai","year":"2021","journal-title":"Pharmaceutical and Clinical Research"},{"issue":"19","key":"10.1016\/j.chmed.2023.02.002_b0075","first-page":"2353","article-title":"Content determination of 17 quality markers in Dahuang Zhechong Pills","volume":"32","author":"Fu","year":"2021","journal-title":"China Pharmacy"},{"issue":"1","key":"10.1016\/j.chmed.2023.02.002_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-019-1474-8","article-title":"Baicalin ameliorates neuroinflammation-induced depressive-like behavior through inhibition of toll-like receptor 4 expression via the PI3K\/AKT\/FoxO1 pathway","volume":"16","author":"Guo","year":"2019","journal-title":"Journal of Neuroinflammation"},{"issue":"1","key":"10.1016\/j.chmed.2023.02.002_b0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3892\/ol.2016.4596","article-title":"Applications of nanoparticle drug delivery systems for the reversal of multidrug resistance in cancer","volume":"12","author":"Huang","year":"2016","journal-title":"Oncology Letters"},{"issue":"8","key":"10.1016\/j.chmed.2023.02.002_b0090","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.chembiol.2019.05.004","article-title":"A systems pharmacology approach uncovers wogonoside as an angiogenesis inhibitor of triple-negative breast cancer by targeting hedgehog signaling","volume":"26","author":"Huang","year":"2019","journal-title":"Cell Chemical Biology"},{"issue":"25","key":"10.1016\/j.chmed.2023.02.002_b0095","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1200\/JCO.2016.69.0032","article-title":"Cell-cycle therapeutics come of age","volume":"35","author":"Ingham","year":"2017","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"10.1016\/j.chmed.2023.02.002_b0100","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3390\/ijms19041232","article-title":"Resistance to anti-angiogenic therapy in cancer\u2014alterations to anti-VEGF pathway","volume":"19","author":"Itatani","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"issue":"9","key":"10.1016\/j.chmed.2023.02.002_b0105","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.3390\/cells8091102","article-title":"Trends and challenges in tumor anti-angiogenic therapies","volume":"8","author":"J\u00e1szai","year":"2019","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.chmed.2023.02.002_b0110","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nrc.2017.53","article-title":"Targeting autophagy in cancer","volume":"17","author":"Levy","year":"2017","journal-title":"Nature Reviews Cancer"},{"issue":"1","key":"10.1016\/j.chmed.2023.02.002_b0115","article-title":"Effects of Dahuang Zhechong Pill on tumor angiogenesis and mechanism in mice with Lewis lung carcinoma","volume":"33","author":"Li","year":"2015","journal-title":"Chinese Archives of Traditional Chinese Medicine"},{"issue":"30","key":"10.1016\/j.chmed.2023.02.002_b0120","first-page":"58","article-title":"Observation on the curative effect of self-made Xiaoliu recipe combined with Dahuang Zhechong Pill in the treatment of 120 cases of uterine fibroids","volume":"9","author":"Li","year":"2011","journal-title":"Chinese and Foreign Medical Research"},{"issue":"6","key":"10.1016\/j.chmed.2023.02.002_b0125","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s40495-017-0106-1","article-title":"Rhodiola rosea L.: An herb with anti-stress, anti-aging, and immunostimulating properties for cancer chemoprevention","volume":"3","author":"Li","year":"2017","journal-title":"Current Pharmacology Reports"},{"key":"10.1016\/j.chmed.2023.02.002_b0130","first-page":"13","article-title":"Dahuang Liaochong Pill in the treatment of 57 cases of malignant tumor","volume":"3","author":"Liu","year":"2001","journal-title":"Jilin Journal of Chinese Medicine"},{"issue":"1","key":"10.1016\/j.chmed.2023.02.002_b0135","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.tcb.2021.07.001","article-title":"Cell cycle on the crossroad of tumorigenesis and cancer therapy","volume":"32","author":"Liu","year":"2022","journal-title":"Trends in Cell Biology"},{"issue":"2","key":"10.1016\/j.chmed.2023.02.002_b0140","first-page":"113","article-title":"Clinical observation on the treatment of chronic myeloid leukemia in chronic phase with Jiawei Dahuang Zhechong Pills combined with hydroxyurea","volume":"36","author":"Liu","year":"2012","journal-title":"Journal of Shandong University of TCM"},{"issue":"9","key":"10.1016\/j.chmed.2023.02.002_b0145","first-page":"632","article-title":"Experimental study on anti-metastasis of H22 liver cancer model mice with Dahuang Zhechong Pill","volume":"29","author":"Lv","year":"2010","journal-title":"Shandong Journal of Traditional Chinese Medicine"},{"issue":"3","key":"10.1016\/j.chmed.2023.02.002_b0150","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/med.21547","article-title":"Therapeutic strategies involving survivin inhibition in cancer","volume":"39","author":"Mart\u00ednez-Garc\u00eda","year":"2019","journal-title":"Medicinal Research Reviews"},{"key":"10.1016\/j.chmed.2023.02.002_b0155","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/978-1-62703-577-4_14","article-title":"Bioassays for anticancer activities","volume":"1055","author":"McCauley","year":"2013","journal-title":"Metabolomics Tools for Natural Product Discovery: Methods and Protocols"},{"issue":"2","key":"10.1016\/j.chmed.2023.02.002_b0160","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1158\/1078-0432.CCR-17-1117","article-title":"Tumor-treating fields: A fourth modality in cancer treatment tumor-treating fields in cancer treatment","volume":"24","author":"Mun","year":"2018","journal-title":"Clinical Cancer Research"},{"issue":"5","key":"10.1016\/j.chmed.2023.02.002_b0165","first-page":"710","article-title":"Advances in basic theory and clinical treatment of anti-cancer effect of Dahuang Zhechong Pill","volume":"25","author":"Ni","year":"2019","journal-title":"Journal of Basic Chinese Medicine"},{"key":"10.1016\/j.chmed.2023.02.002_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112332","article-title":"Investigation of the pharmacodynamic substances in Dahuang Zhechong Pill that inhibit energy metabolism","volume":"251","author":"Ni","year":"2020","journal-title":"Journal of Ethnopharmacology"},{"issue":"16","key":"10.1016\/j.chmed.2023.02.002_b0175","doi-asserted-by":"crossref","first-page":"e19757","DOI":"10.1097\/MD.0000000000019757","article-title":"A clinical study of traditional Chinese medicine prolonging the survival of advanced gastric cancer patients by regulating the immunosuppressive cell population: A study protocol for a multicenter, randomized controlled trail","volume":"99","author":"Pan","year":"2020","journal-title":"Medicine"},{"issue":"14","key":"10.1016\/j.chmed.2023.02.002_b0180","doi-asserted-by":"crossref","first-page":"261","DOI":"10.21037\/atm.2016.04.01","article-title":"Harnessing the immune system to improve cancer therapy","volume":"4","author":"Papaioannou","year":"2016","journal-title":"Annals of Translational Medicine"},{"issue":"4","key":"10.1016\/j.chmed.2023.02.002_b0185","doi-asserted-by":"crossref","first-page":"603","DOI":"10.18632\/aging.100934","article-title":"Apoptosis as anticancer mechanism: Function and dysfunction of its modulators and targeted therapeutic strategies","volume":"8","author":"Pistritto","year":"2016","journal-title":"Aging (Albany NY)"},{"issue":"11","key":"10.1016\/j.chmed.2023.02.002_b0190","first-page":"15","article-title":"Clinical study on lung cancer treated by Dahuang Zhechong Pill","volume":"18","author":"Qi","year":"2011","journal-title":"Chinese Journal of Information on Traditional Chinese Medicine"},{"key":"10.1016\/j.chmed.2023.02.002_b0195","series-title":"Clinical and experimental study on the BCR\/ABL-negative myeloproliferative neoplasms by adding Rhubarb Zhechong Pill","author":"Qin","year":"2015"},{"issue":"5","key":"10.1016\/j.chmed.2023.02.002_b0200","first-page":"423","article-title":"Effects of Dahuang Zhechong pill on chronic myeloeytic leukemia K562 cell proliferation and apoptosis","volume":"56","author":"Qin","year":"2015","journal-title":"Journal of Traditional Chinese Medicine"},{"key":"10.1016\/j.chmed.2023.02.002_b0205","series-title":"Literature and experimental research on antitumor of Dahuang Zhechong Pill","author":"Qu","year":"2016"},{"issue":"2","key":"10.1016\/j.chmed.2023.02.002_b0210","first-page":"191","article-title":"Literature study of Dahuang Zhechong Pill in the treatment of tumor","volume":"39","author":"Ren","year":"2019","journal-title":"Jilin Journal of Chinese Medicine"},{"issue":"3","key":"10.1016\/j.chmed.2023.02.002_b0215","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cld.2007.06.012","article-title":"Cancer chemotherapy II: A typical hepatic injuries","volume":"11","author":"Rodriguez-Frias","year":"2007","journal-title":"Clinics in Liver Disease"},{"issue":"1","key":"10.1016\/j.chmed.2023.02.002_b0220","first-page":"44","article-title":"Effect of Dahuang Zhechong Pill on development of colon cancer in CT26 mice by inhibiting the expression of CCL17","volume":"32","author":"Ruan","year":"2021","journal-title":"Traditional Chinese Drug Research and Clinical Pharmacology"},{"key":"10.1016\/j.chmed.2023.02.002_b0225","first-page":"9","article-title":"Traditional Chinese medicine treatment of 62 cases of primary lung cancer","volume":"7","author":"Shen","year":"1982","journal-title":"Shanghai Journal of Traditional Chinese Medicine"},{"issue":"8","key":"10.1016\/j.chmed.2023.02.002_b0230","first-page":"1807","article-title":"Mechanism on inhibition of Lewis lung carcinoma in mice with Dahuang Zhechong Pills","volume":"29","author":"Shu","year":"2011","journal-title":"Chinese Archives of Traditional Chinese Medicine"},{"issue":"1","key":"10.1016\/j.chmed.2023.02.002_b0240","first-page":"7","article-title":"Cancer statistics","volume":"72","author":"Siegel","year":"2022","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"6","key":"10.1016\/j.chmed.2023.02.002_b0235","first-page":"804","article-title":"Effects of Dahuang Zhechong Pills on CD44, VEGF and the metastasis suppressor in mice with Lewis lung carcinoma","volume":"24","author":"Shu","year":"2009","journal-title":"China Journal of Traditional Chinese Medicine and Pharmacy"},{"key":"10.1016\/j.chmed.2023.02.002_b0245","series-title":"The mechanism study of Dahuangzhechong bolus on liver cancer","author":"Song","year":"2011"},{"issue":"2","key":"10.1016\/j.chmed.2023.02.002_b0250","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/14737140.2020.1718496","article-title":"Novel therapeutic targets for cancer metastasis","volume":"20","author":"Stoletov","year":"2020","journal-title":"Expert Review of Anticancer Therapy"},{"issue":"21","key":"10.1016\/j.chmed.2023.02.002_b0255","first-page":"4872","article-title":"Clinical study of Dahuang Zhechong Pill combined with chemotherapy in the treatment of pancreatic cancer with blood addiction syndrome","volume":"25","author":"Sun","year":"2014","journal-title":"Modern Diagnosis and Treatment"},{"issue":"6","key":"10.1016\/j.chmed.2023.02.002_b0260","first-page":"1040","article-title":"Protective effect of emodin on lipopolysaccharide induced oxidative damage of vascular endothelial cells by regulating TLR4\/NF-\u03baB pathway","volume":"43","author":"Sun","year":"2020","journal-title":"Drug Evaluation Research"},{"issue":"3","key":"10.1016\/j.chmed.2023.02.002_b0265","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"3","key":"10.1016\/j.chmed.2023.02.002_b0270","first-page":"266","article-title":"Morphological study on apoptosis of tumor cells induced by Dahuang Zhechong pills","volume":"31","author":"Tian","year":"2011","journal-title":"Jilin Journal of Traditional Chinese Medicine"},{"issue":"1","key":"10.1016\/j.chmed.2023.02.002_b0275","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev-immunol-031210-101324","article-title":"Natural innate and adaptive immunity to cancer","volume":"29","author":"Vesely","year":"2011","journal-title":"Annual Review of Immunology"},{"issue":"11","key":"10.1016\/j.chmed.2023.02.002_b0280","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/nm.3391","article-title":"Tumor metastasis: Moving new biological insights into the clinic","volume":"19","author":"Wan","year":"2013","journal-title":"Nature Medicine"},{"issue":"10","key":"10.1016\/j.chmed.2023.02.002_b0285","first-page":"2005","article-title":"The effect of Dahuang Zhechong pill on tumor cell apoptosis in tumor-bearing mice","volume":"26","author":"Wang","year":"2011","journal-title":"Guangming Journal of Chinese Medicine"},{"key":"10.1016\/j.chmed.2023.02.002_b0290","first-page":"53","article-title":"Dahuang Zhechong Pill mainly in the treatment of advanced malignant tumor","volume":"5","author":"Wen","year":"2004","journal-title":"Journal of Shanxi University of Chinese Medicine"},{"issue":"1","key":"10.1016\/j.chmed.2023.02.002_b0295","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1172\/JCI73941","article-title":"The role for autophagy in cancer","volume":"125","author":"White","year":"2015","journal-title":"The Journal of Clinical Investigation"},{"issue":"6","key":"10.1016\/j.chmed.2023.02.002_b0300","first-page":"939","article-title":"Experimental study on anti-recurrence and metastasis of liver tumor with Dahuang Zhechong Pills","volume":"35","author":"Wu","year":"2008","journal-title":"Liaoning Journal of Traditional Chinese Medicine"},{"issue":"11","key":"10.1016\/j.chmed.2023.02.002_b0305","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.7150\/ijbs.16334","article-title":"Aloe-emodin suppresses hypoxia-induced retinal angiogenesis via inhibition of HIF-1\u03b1\/VEGF pathway","volume":"12","author":"Wu","year":"2016","journal-title":"International Journal of Biological Sciences"},{"issue":"10","key":"10.1016\/j.chmed.2023.02.002_b0310","first-page":"54","article-title":"Dahuang Zhechong Pill with chemotherapy in the treatment of primary carcinoma of liver at middle-advanced stage","volume":"24","author":"Wu","year":"2011","journal-title":"Western Journal of Traditional Chinese Medicine"},{"key":"10.1016\/j.chmed.2023.02.002_b0315","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jep.2018.03.039","article-title":"Effects of Dahuang zhechong pill on doxorubicin-resistant SMMC-7721 xenografts in mice","volume":"222","author":"Wu","year":"2018","journal-title":"Journal of Ethnopharmacology"},{"key":"10.1016\/j.chmed.2023.02.002_b0320","doi-asserted-by":"crossref","first-page":"6279576","DOI":"10.1155\/2017\/6279576","article-title":"Dahuang Zhechong Pill combined with doxorubicin induces cell death through regulating energy metabolism in human hepatocellular carcinoma cells","volume":"2017","author":"Wu","year":"2017","journal-title":"Evidence-Based Complementary and Alternative Medicine"},{"issue":"12","key":"10.1016\/j.chmed.2023.02.002_b0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1934578X19888079","article-title":"Investigation on the characteristic components of Dahuang Zhechong Pill based on high-performance liquid chromatography (HPLC) fingerprint","volume":"14","author":"Wu","year":"2019","journal-title":"Natural Product Communications"},{"key":"10.1016\/j.chmed.2023.02.002_b0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2020.122200","article-title":"Simultaneous determination of nineteen compounds of Dahuang zhechong pill in rat plasma by UHPLC-MS\/MS and its application in a pharmacokinetic study","volume":"1151","author":"Wu","year":"2020","journal-title":"Journal of Chromatography B"},{"key":"10.1016\/j.chmed.2023.02.002_b0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154055","article-title":"Multi-material basis and multi-mechanisms of the Dahuang Zhechong pill for regulating Treg\/Th1 balance in hepatocellular carcinoma","volume":"100","author":"Wu","year":"2022","journal-title":"Phytomedicine"},{"issue":"5","key":"10.1016\/j.chmed.2023.02.002_b0340","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1002\/cam4.2108","article-title":"Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science","volume":"8","author":"Xiang","year":"2019","journal-title":"Cancer Medicine"},{"issue":"2","key":"10.1016\/j.chmed.2023.02.002_b0345","first-page":"46","article-title":"Influence of Dahuang Zhechong Pill on related indexes of liver fibrosis induced by interventional therapy for hepatocellular carcinoma","volume":"37","author":"Xie","year":"2014","journal-title":"Guangxi Journal of Traditional Chinese Medicine"},{"key":"10.1016\/j.chmed.2023.02.002_b0350","series-title":"Clinical study on pancreatic cancer treated by \u201cDahuang zhe chong wan\u201d combined with chemotherapy","author":"Xu","year":"2010"},{"issue":"19","key":"10.1016\/j.chmed.2023.02.002_b0355","first-page":"16","article-title":"Treating advanced malignances mainly with Dahuang Zhechong Pill","volume":"5","author":"Yang","year":"2013","journal-title":"Clinical Journal of Chinese Medicine"},{"key":"10.1016\/j.chmed.2023.02.002_b0360","series-title":"The experimental study of Dahuang Zhechong Bolus\u2019s immunoregulation on mice of tumor of liver H22","author":"Zhai","year":"2007"},{"issue":"1","key":"10.1016\/j.chmed.2023.02.002_b0365","first-page":"54","article-title":"Simultaneous determination of 6 kinds of constituent in Dahuang Zhechong Pills by HPLC-PDA","volume":"30","author":"Zhang","year":"2019","journal-title":"China Pharmacy"},{"key":"10.1016\/j.chmed.2023.02.002_b0370","series-title":"Experimental study on the effect of Dahuang Zhechong Pill on immune mechanism of Lewis lung cancer tumor-bearing mice","author":"Zhang","year":"2015"},{"key":"10.1016\/j.chmed.2023.02.002_b0375","series-title":"Research on the activity ingredient screening and pharmacokinetics of Dahuang Zhechong Pills in liver cancer treating","author":"Zhang","year":"2019"},{"issue":"5","key":"10.1016\/j.chmed.2023.02.002_b0380","doi-asserted-by":"crossref","first-page":"283","DOI":"10.5582\/bst.2021.01318","article-title":"The positive role of traditional Chinese medicine as an adjunctive therapy for cancer","volume":"15","author":"Zhang","year":"2021","journal-title":"Bioscience Trends"},{"issue":"1","key":"10.1016\/j.chmed.2023.02.002_b0385","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jep.2009.04.012","article-title":"Mechanisms of inhibiting proliferation of vascular smooth muscle cells by serum of rats treated with Dahuang Zhechong pill","volume":"124","author":"Zhang","year":"2009","journal-title":"Journal of Ethnopharmacology"},{"issue":"9","key":"10.1016\/j.chmed.2023.02.002_b0390","first-page":"27","article-title":"Observation on the curative effect of Dahuang Zhechong pill combined with Zhongjiefeng tablet in the treatment of 38 cases of ovarian cyst","volume":"28","author":"Zhao","year":"2008","journal-title":"Henan Traditional Chinese Medicine"},{"issue":"11","key":"10.1016\/j.chmed.2023.02.002_b0395","first-page":"1463","article-title":"15 Cases of primary liver cancer treated by Dahuang Zhechong Pill","volume":"33","author":"Zhao","year":"2006","journal-title":"Liaoning Journal of Traditional Chinese Medicine"},{"issue":"8","key":"10.1016\/j.chmed.2023.02.002_b0400","first-page":"130","article-title":"Clinical observation of DHZCP combined with realgar in the treatment of multiple myeloma","volume":"11","author":"Zheng","year":"2009","journal-title":"Journal of Liaoning University of Traditional Chinese Medicine"},{"issue":"2","key":"10.1016\/j.chmed.2023.02.002_b0405","first-page":"161","article-title":"Clinical observation of Dahuang Zhechong Pill combined with gemcitabine and oxaliplatin in the treatment of primary liver cancer","volume":"46","author":"Zhou","year":"2014","journal-title":"Journal of New Chinese Medicine"}],"container-title":["Chinese Herbal Medicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S167463842300028X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S167463842300028X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T12:29:07Z","timestamp":1761654547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S167463842300028X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":81,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S167463842300028X"],"URL":"https:\/\/doi.org\/10.1016\/j.chmed.2023.02.002","relation":{},"ISSN":["1674-6384"],"issn-type":[{"value":"1674-6384","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical antitumor application and pharmacological mechanisms of Dahuang Zhechong Pill","name":"articletitle","label":"Article Title"},{"value":"Chinese Herbal Medicines","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chmed.2023.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Tianjin Press of Chinese Herbal Medicines. Published by ELSEVIER B.V.","name":"copyright","label":"Copyright"}]}}